Dermata Therapeutics, Inc. Stock Forecast

Dermata Therapeutics, Inc. stock price down 0% on Monday
(Updated on Jun 17, 2024)

DRMAW Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 10, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Dermata Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0073 and $0.0105. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Sell

Special Signal Notification

Double Top Formation

A sell signal from a double top formation was found on Friday, May 17, 2024 and based on theory for this formation the price should fall by -98.57% to $0.0001 within 2 trading days since signal was issued (Tuesday, June 18, 2024).

Support, Risk & Stop-loss for Dermata Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 25.43%

Dermata Therapeutics, Inc. is oversold on RSI14 (26). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $0.0065 (-6.48%) (This stock has low daily movements and this gives low risk. Low RSI14 is 26 which reduces the risk some. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (DRMAW) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Dermata Therapeutics, Inc. to open at $0.0070, and during the day (based on 14 day Average True Range), to move between $0.0041 and $0.0099, which gives a possible trading interval of +/-$0.0029 (+/-40.75%) up or down from last closing price. If Dermata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 81.49% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0081, some $0.0011 (15.71%) from the current price of $0.0070, our system finds the risk reward not very attractive.

Is Dermata Therapeutics, Inc. stock A Buy?

Dermata Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Dermata Therapeutics, Inc. of Tuesday, June 18, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.